A Bayesian hierarchical analysis of Mediterranean croplands revealed that machine learning algorithm selection shapes soil ...
This pharmaceutical-development technology company continues to demonstrate that its testing platform has real potential.
The AI-driven biotech has secured FDA alignment on a pivotal trial for its FAP therapy, with a study start planned for 2027.
If you picked Recursion Pharmaceuticals for its AI-first pitch and deep pharma ties, the past year has probably felt rough.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
Recursion Pharmaceuticals had aligned with the FDA on the design of its registrational Phase 3 trial of REC-4881, an ...
Recursion Pharmaceuticals said on November 18, 2026 that it had aligned with the U.S. Food and Drug Administration on a ...
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
This article presents links to and descriptions of built-in operators and functions for strings and binary types, numeric scalars, aggregations, windows, arrays, maps, dates and timestamps, casting, ...
The aim of the programme is to offer a deep and up-to-date education in data science, machine learning and artificial intelligence that prepares graduates with key knowledge, skills and competencies ...